Guardant Health’s precision oncology tests - Guardant RevealTM, Guardant360® CDx, and Guardant360 TissueNextTM are now available from Codex Genetics.

#NF2

Neurofibromatosis

Date：2022-03-02

Product
Hereditary Cancer TestNeurodegenerative Disease TestDrug Response TestCongenital Cardiovascular DiseaseGuardant Health Pan-Cancer TestGuardant Shield™Retinitis PigmentosaSample collection guidelinePrivacy Policy
About Us
Our Team Codex Cares News and Events Hub FAQ Contact Us Blog Careers

Pinpointing genetic uniqueness

Order Now
instagram linkedin facebook
The services provided by Codex Genetics are for research use only, and they are not suitable for diagnostic and/or treatment use, unless otherwise instructed by licensed medical professionals.
除非有醫療專業人員另行指示，此網站的服務只供研究用途，並不供作診斷或治療任何疾病之用。
Codex Genetics Limited © 2024. CoGenesis® is a trademark of Codex Genetics Limited